Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

1986 • 609 citations

1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE

1977 • 597 citations

Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes

1982 • 369 citations

DIABETIC KETOACIDOSIS

1974 • 363 citations

Platelet Aggregation Induced by I-Desamino-8-D-Arginine Vasopressin (dDAVP) in Type IIb von Willebrand's Disease

1983 • 260 citations

Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time

1986 • 212 citations

Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP)

1992 • 187 citations

Response of Patients with Mild and Moderate Hemophilia A and von Willebrand's Disease to Treatment with Desmopressin

1985 • 166 citations

MILK FOR BABIES

1975 • 138 citations

Myocardial infarction in a patient with hemophilia treated with DDAVP.

1988 • 121 citations

Thrombosis following desmopressin for uremic bleeding

1988 • 114 citations

Desmopressin and bleeding time in patients with cirrhosis.

1985 • 113 citations

DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand disease

1983 • 100 citations

Ddavp-induced correction of prolonged bleeding time in patients with congenital platelet function defects

1987 • 95 citations

DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor

1989 • 94 citations

Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time

1986 • 88 citations

Effect of 1-Deamino-8-D-Arginine Vasopressin on the Prolonged Bleeding Time in Chronic Renal Failure

1982 • 84 citations

DDAVP‐induced enhancement of platelet retention: Its dependence on platelet‐von Willebrand Factor and the platelet receptor GP IIb/IIIa

1992 • 66 citations

Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients

2008 • 55 citations

1-Desamino-8-D-arginine Vasopressin (Desmopressin) Shortens the Bleeding Time in Storage Pool Deficiency

1988 • 54 citations

Subcutaneous Desmopressin (DDAVP) Shortens the Prolonged Bleeding Time in Patients with Liver Cirrhosis

1990 • 52 citations

Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgery

1987 • 50 citations

DDAVP in type IIa von Willebrand's disease

1986 • 47 citations

Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.

1995 • 42 citations

Continuous infusion of atracurium in ARDS patients

1997 • 1 citations

Cited By (0)

Loading...